Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2025-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This falls under the category of official results from shareholder votes at a general meeting.
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically the reappointment of outside directors, including their names, terms, and professional backgrounds. This falls directly under the category of Board/Management Information.
2025-03-28 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 16th fiscal year (2024), which is the standard Korean terminology for an Annual Report (10-K equivalent). It contains comprehensive company information, including corporate history, management details, capital structure, and governance, as required by the Financial Supervisory Service and Korea Exchange. It is not an announcement or a summary, but the full report itself. FY 2024
2025-03-20 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings, citing internal audit and preparation schedules. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2025-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for U2Bio Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, director appointments, remuneration limits), and detailed management reference materials (business overview, industry analysis, and board activity reports). This document is a standard proxy statement/notice package provided to shareholders to inform them of the upcoming AGM and solicit their votes. In the context of the provided filing types, this aligns with 'Proxy Solicitation & Information Statement'.
2025-03-13 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company U2Bio. It provides the audit opinion (unqualified/proper), key financial data, and confirms the receipt of the audit report from the external auditor (Seohyun Accounting Corporation). While it contains financial data, it is a standard regulatory announcement notifying the market that the audit report has been submitted, rather than the full annual report document itself. Therefore, it falls under the category of a Report Publication Announcement (RPA). FY 2024
2025-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.